Nice to get a mention for our latest funding round in the Cambridge Business Weekly. The management and board are delighted with the support received from old and new shareholders alike.
Cambridge UK medical technology business Camstent has raised £850k from a combination of existing and new investors in a key funding round. Due to widespread interest in the company’s patented bacteria-phobic polymer coatings, the initial investment target of £300,000 was extended, nearly trebling the total amount raised during the round. Currently one in 20 inpatients suffer from a Hospital Acquired Infection (HAI), leading to the loss of thousands of lives globally and adding to costs for healthcare providers. Government research found that even a 10 per cent reduction in infections could save the NHS £100 million a year. Camstent’s patented bacteria-phobic polymer coatings are said to help better protect against HAIs by changing the physical properties of surfaces to make them inhospitable to bacteria – thus reducing colonisation and dramatically lowering infection rates.